Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.65M Sell
4,684
-98
-2% -$34.9K 0.45% 56
2025
Q4
$1.57M Buy
4,782
+82
+2% +$26K 0.44% 59
2025
Q3
$1.33M Sell
4,700
-34
-0.7% -$9.86K 0.39% 68
2025
Q2
$1.32M Buy
4,734
+106
+2% +$30K 0.41% 66
2025
Q1
$1.44M Buy
4,628
+456
+11% +$135K 0.48% 58
2024
Q4
$1.09M Buy
4,172
+47
+1% +$13.9K 0.4% 72
2024
Q3
$1.33M Buy
4,125
+31
+0.8% +$10.1K 0.49% 56
2024
Q2
$1.28M Buy
4,094
+262
+7% +$77K 0.51% 53
2024
Q1
$1.09M Buy
3,832
+134
+4% +$39.2K 0.43% 60
2023
Q4
$1.06M Buy
3,698
+8
+0.2% +$2.18K 0.47% 60
2023
Q3
$992K Buy
3,690
+274
+8% +$68.4K 0.45% 56
2023
Q2
$758K Buy
3,416
+70
+2% +$16.2K 0.35% 70
2023
Q1
$809K Buy
3,346
+156
+5% +$38.3K 0.39% 69
2022
Q4
$838K Buy
3,190
+143
+5% +$38.3K 0.43% 62
2022
Q3
$687K Buy
3,047
+123
+4% +$29.8K 0.4% 64
2022
Q2
$711K Buy
2,924
+90
+3% +$22.1K 0.4% 68
2022
Q1
$685K Sell
2,834
-2,427
-46% -$558K 0.37% 76
2021
Q4
$1.18M Buy
5,261
+532
+11% +$112K 0.64% 49
2021
Q3
$1.01M Buy
4,729
+876
+23% +$202K 0.58% 55
2021
Q2
$939K Buy
3,853
+478
+14% +$118K 0.57% 53
2021
Q1
$840K Sell
3,375
-1,030
-23% -$246K 0.54% 51
2020
Q4
$1.01M Buy
4,405
+375
+9% +$86.5K 0.62% 48
2020
Q3
$1.02M Buy
4,030
+17
+0.4% +$4.21K 0.7% 37
2020
Q2
$946K Buy
4,013
+2,743
+216% +$626K 0.72% 36
2020
Q1
$257K Sell
1,270
-2,380
-65% -$520K 0.26% 96
2019
Q4
$880K Buy
+3,650
New +$805K 0.66% 33

Other funds holding AMGN

Argent Advisors's AMGN Position: Q1 2026 in Review

Argent Advisors reduced its Amgen (AMGN) stake by 2% in Q1 2026, selling an estimated $34.9K and leaving 4,684 shares worth $1.65M. The position accounts for 0.45% of the portfolio, ranked #56.

Argent Advisors first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Argent Advisors held 4,684 shares of Amgen worth $1.65M as of Q1 2026.
  • Argent Advisors sold 98 Amgen shares in Q1 2026, an estimated $34.9K.
  • Amgen made up 0.45% of Argent Advisors's portfolio in Q1 2026, its #56 holding.
  • Argent Advisors first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Argent Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.